Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Oct 15 - Oct 20
63 FriedenM.JamesD.CastelbouC.DanckaertA.MartinouJ
Phase 2 is hypothesis-generating
the present invention furthermore relates to a BPC peptide salt or a pharmaceutical or diagnostic composition according to the above wherein the general formula (II) is the present invention relates in particular to a BPC peptide salt or a pharmaceutical or diagnostic composition a BPC peptide salt or a pharmaceutical or diagnostic composition comprising a salt of a BPC peptide according to the above general formula (I) wherein the peptide is selected from the group consisting of: the peptides may be linked to other functional and/or structural moieties such as carbohydrates, fats, proteins or peptides, antibodies, receptors, hormones, cytotoxic substances, marker substances, dyes, radioactive labels, immunomodulatory agents, drugs, carriers, targeting or signalling substances, etc
Also see our Top Picks for dark chocolates and cocoa powders
This compromises its bacteriostatic properties, rendering the vial unsafe for multiple uses
The formula you need to remember Units to draw = (desired dose in mg / concentration in mg per mL) x 100 That single formula, combined with your known concentration, handles every dosing scenario you will encounter across your entire protocol
